The Victorian Heart Hospital and Victorian Heart Institute, operated by Monash Health in partnership with Monash University, have led a groundbreaking first-in-human trial of a gene-editing therapy that could permanently lower cholesterol and triglyceride levels in people with difficult-to-treat lipid disorders.
Monash leads world-first trial of cholesterol-lowering gene-editing therapy
November 10, 2025 Latest NewsBioPharmaAustralian Biotech
Latest Video
New Stories
-
Medicines Australia tells productivity inquiry PBS rules leave out economic benefits
November 16, 2026 - -
First official US count confirms the broad uptake of GLP-1s for weight management
November 16, 2026 - - Latest News -
Can the PBS afford another agreement on the same terms?
November 16, 2026 - - Latest News -
The 'Dispatched' Week in Review Podcast - 13 November
November 13, 2026 - - Podcast -
A year on, Sanofi now asks staff to explain how they used AI
November 13, 2026 - - Latest News -
There is no need for AI to automate the care out of healthcare, Cohn warns
November 13, 2026 - -
Cochlear's global government affairs chief is putting AI to work
November 13, 2026 - - Latest News

